Compumedics (ASX:CMP) has secured an order worth around AU$4.2 million for its Orion LifeSpan magnetoencephalography (MEG) system from Shandong Normal University in China, according to a Thursday Australian bourse filing.
The order marks the company's sixth MEG system sale, bringing total contracted MEG orders to about AU$30 million, the filing said.
The order includes the dual-helmet MEG platform, CURRY neuro-imaging software, and peripherals, with delivery and revenue expected in fiscal year 2027, the filing added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments